rHIgM22 for MS relapse
IS YOUR MS trying to make a comeback?
Take part in a study for people who are currently experiencing an MS relapse.
rHIgM22 is a human antibody that has promoted remyelination (promotion of new myelin formation) in early preclinical studies.
This study will help to assess the safety and tolerability in people with MS immediately following a relapse.